1-3 of 3
Lize Fie Ditteke Van Vulpen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pharmacokinetic-Guided Reduction of Emicizumab in Patients with Congenital Hemophilia a in the Netherlands: Interim Analysis from the Dosemi Study

Konrad Van Der Zwet, Marjon H. Cnossen, Floor CJI Moenen, Saskia EM Schols, Paula F Ypma, Paul L. den Exter, Louise Hooimeijer, Michiel Coppens, Ron A.A. Mathôt, Anouk A.M.T. Donners, Alexander Janssen, Ilmar Kruis, Eduard J. Van Beers, Corien L. Eckhardt, Rolf T. Urbanus, Lize Fie Ditteke Van Vulpen, Roger EG Schutgens, Kathelijn Fischer
Journal: Blood
Blood (2024) 144 (Supplement 1): 127.
https://doi.org/10.1182/blood-2024-193995
Published: 2024
Journal Articles

Evaluating the Clinical Relevance of Thrombin Generation Potential during Emicizumab Therapy

Konrad Van Der Zwet, Mark Roest, Dana Huskens, Eduard J. Van Beers, Kathelijn Fischer, Lize Fie Ditteke Van Vulpen, Roger EG Schutgens, Rolf T. Urbanus
Journal: Blood
Blood (2024) 144 (Supplement 1): 3960.
https://doi.org/10.1182/blood-2024-204587
Published: 2024
Journal Articles

Mim8 Prophylaxis Beyond Bleeding: Investigating Multifaceted, Patient-Reported Outcomes for Hemophilia A in the FRONTIER2 Study

Cedric Hermans, Cihan Ay, Carmen Escuriola, Peter Kampmann, Rikke Medom Meldgaard, Ilgiz Rakhmatullin, Ciprian Tomuleasa, Lize Fie Ditteke van Vulpen, Michael Wang, Irena Woźnica-Karczmarz, Sophie Susen
Journal: Blood
Blood (2024) 144 (Supplement 1): 1212.
https://doi.org/10.1182/blood-2024-198395
Published: 2024